| Financial Year |
March 31 2023 |
| Monetary Funds |
4,795,768,189.61 |
| Held-for-trading Financial Assets |
14,180,137.86 |
| Notes Receivable |
9,625,116.09 |
| Accounts Receivable |
2,855,931,216.50 |
| Advances to Suppliers |
260,705,028.77 |
| Other Receivables |
105,306,989.06 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
10,769,424,852.66 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
68,767,113.49 |
| Other Current Assets |
78,708,690.06 |
| Total Current Assets |
19,150,253,459.78 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
6,046,883.61 |
| Long-term Equity Investment |
534,069,528.46 |
| Investment Properties |
250,082,745.69 |
| Fixed Assetes |
2,082,815,525.64 |
| Under-construction Projects |
537,231,169.39 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,347,750,382.42 |
| R&D expenses |
825,755,074.08 |
| Goodwill |
3,876,673,410.71 |
| Long-Term Deferred and Prepaid Expenses |
201,865,938.68 |
| Deferred Income Tax Assets |
437,453,629.86 |
| Other Non-Current Assets |
961,096,538.16 |
| Sub-Total of Non-Current Assets |
17,511,162,419.97 |
| Total Assets |
36,661,415,879.75 |
| Short-Term Loans |
4,704,759,722.85 |
| Trading Financial liabilities |
256,000,000.00 |
| Notes Payable |
-- |
| Accounts Payable |
1,144,372,360.61 |
| Accounts Received In Advance |
3,142,177.86 |
| Employee Compensation Payable |
172,591,762.06 |
| Taxes Payable |
130,779,464.59 |
| Interest Payable |
-- |
| Dividend Payable |
4,270,095.24 |
| Other payables |
1,421,182,641.05 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,470,748,463.83 |
| Other Current Liabilities |
825,607.16 |
| Sub-Total of Current Liabilities |
10,545,296,027.26 |
| Long-term Loans |
3,601,227,898.42 |
| Bonds Payable |
2,370,249,631.85 |
| Long-Term Accounts Payable |
16,633,485.84 |
| Special Payable |
-- |
| Estimatied Liabilities |
977,095,114.09 |
| Deferred Income Tax Liabilities |
639,781,321.65 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
7,777,592,799.79 |
| Total Liabilities |
18,322,888,827.05 |
| Paid-In Capital(Or Share Stock) |
1,184,178,919.00 |
| Capital Surplus |
8,344,163,729.61 |
| Surplus Reserve |
126,920,523.27 |
| LESS:Treasury Stock |
526,452,216.62 |
| Undistributed Profits |
8,770,526,205.87 |
| Minority Stockholder's Interest |
74,597,642.73 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
18,263,929,409.97 |
| Owner's Equity（Stockholder's Equity） |
18,338,527,052.70 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
36,661,415,879.75 |
